pillbase.ru

Retsevmo

Active substance: selpercatinib

selpercatinib

Centralised EU authorisationActive

Marketing holder: Eli Lilly Nederland B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 6
  • RETEVMO
    TABLET, COATED · SELPERCATINIB 120 mg/1
    0002-6120
    Eli Lilly and Company
  • RETEVMO
    TABLET, COATED · SELPERCATINIB 160 mg/1
    0002-5562
    Eli Lilly and Company
  • RETEVMO
    CAPSULE · SELPERCATINIB 80 mg/1
    0002-2980
    Eli Lilly and Company
  • RETEVMO
    TABLET, COATED · SELPERCATINIB 40 mg/1
    0002-5340
    Eli Lilly and Company
  • RETEVMO
    CAPSULE · SELPERCATINIB 40 mg/1
    0002-3977
    Eli Lilly and Company
All products in this country (6)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12090-cfd7-7720-835f-835973329cd4,01a12092-8bd9-7f6c-8db8-575873f00160,01a12093-7e0e-792a-9bdf-5525a52a65ed,01a12094-dcb2-75a4-8735-578385a4a04a,01a12098-f60e-782c-82ad-d7eeaaf72f82;count=6 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005375
Registration status
Active
ATC code
L01EX22
Sources
  • product · EMA · EMEA/H/C/005375 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005375 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005375 · Verified 2026-10-09